Search for: "Majors v. Pfizer, Inc."
Results 1 - 20
of 167
Sort by Relevance
|
Sort by Date
10 Mar 2024, 7:51 am
Pfizer Inc., 646 F. [read post]
20 Dec 2023, 5:00 am
Major industry players filed amici briefs on both sides, AbbVie, Bristol Meyers Squibb, and Merck supporting Amgen, and Pfizer, Eli Lilly, Genentech, and AstraZeneca supporting Sanofi. [read post]
19 Oct 2023, 8:59 am
[LexisNexis Commentary: This IMR is particularly interesting because the medication Geodon, which was at issue here, was the subject of a $301 million settlement between Pfizer, Inc. and the U.S. [read post]
3 Jan 2023, 1:47 pm
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
2 Sep 2022, 5:01 am
"[5] That may be especially true for minority religious communities' confidence in the secular judiciary, since many minority religions and denominations might have special reasons to distrust the majority's legal system.[6] To be sure, the plaintiff might understandably worry that those coreligionists will resent him for suing, and may shun him or refuse to do business with him. [read post]
19 Apr 2022, 5:05 am
We also offer some examples of major AKS cases. [read post]
17 Oct 2021, 2:17 pm
Kehm v. [read post]
3 Sep 2021, 10:21 am
Children’s Health Defense v. [read post]
13 Jul 2021, 10:58 am
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]
14 Oct 2020, 8:48 am
Pfizer, Inc. [read post]
14 Oct 2020, 8:48 am
Pfizer, Inc. [read post]
17 Sep 2020, 4:55 am
” It returned the following statement from the case Frlekin v. [read post]
30 Jun 2020, 6:59 am
Inc. v. [read post]
23 Jan 2020, 10:37 pm
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
18 Apr 2018, 7:15 am
It shows how a group of lower-middle class New London, Connecticut homeowners found themselves steamrolled by a plan to take their land in order to facilitate a development project backed by powerful political forces, including Connecticut Governor John Rowland, the New London Development Corporation (the private organization that planned and conducted the takings on behalf of the City of New London), and Pfizer, Inc., a major pharmaceutical firm that hoped to benefit from… [read post]
25 Aug 2017, 6:54 pm
” Pfizer, Inc. v. [read post]
31 Jul 2017, 7:00 am
See generally Opposition Brief of Defendants-Appellees Pfizer Inc., Pfizer International LLC, and Greenstone LLC [cited as Pfizer]. [read post]
21 Jun 2016, 4:00 am
Absent more definitive consistent instruction from the Federal Court of Appeal, or direct SCC pronouncement on the proper approach, patent drafters are still advised to keep their promises to a minimum to avoid disclosure challenges regarding sound prediction. _________________________ [1] Eli Lilly v Hospira 2016 FC 47 (Barnes) [2] Gilead v Idenix 2015 FC 1156 at para 381 (Annis), under appeal A-483-15, adopting earlier reasoning of Astra v Apotex 2014 FC 638 (Rennie),… [read post]
25 Mar 2016, 3:16 pm
Tyson Foods, Inc. v. [read post]
3 Mar 2016, 5:19 am
Pfizer, Inc., 153 S.W.3d 758, 766 (Ky. 2004) (DTC exception “recognized only by New Jersey”); Mendez Montes De Oca v. [read post]
